Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07186816 · ClinicalTrials.gov registry record · NA
SUpport From PEeRs to Expand Access Study - Community
A NA study of Depression, Anxiety, sponsored by University of California, Berkeley.
- Recruiting
- Registry status
- NA
- Development phase
- 213
- Enrollment target
- 1
- Study location
NCT07186816: Recruiting NA study of Depression, Anxiety, sponsored by University of California, Berkeley.
NCT07186816 is a NA study of Depression, Anxiety that is actively recruiting participants, run by University of California, Berkeley. The registered enrollment target is 213 participants, below the 419-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07186816, a NA study of Depression, Anxiety, is actively recruiting participants, sponsored by University of California, Berkeley.
- RECRUITING
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing self-guided vs. supported dCBT (SilverCloud).
Primary Outcome
The primary outcome of symptoms of depression will be measured with the self-report Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item self-report measure of depression. Scores on this measure range from 0 (Not At All) to 3 (Nearly Every Day).
Conditions Studied
Interventions
- DEVICE Behavioral: Supported dCBT
- DEVICE Behavioral: Unsupported dCBT
Study Locations (1)
California
- Zuckerberg San Francisco General - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT07186816 shows while recruiting
NCT07186816 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 419-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Behavioral: Supported dCBT is the first listed.
NCT07186816 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07186816 about?
NCT07186816 is a clinical study titled "SUpport From PEeRs to Expand Access Study - Community". Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing...
What is the current status of trial NCT07186816?
This trial is currently recruiting. It is a NA study. The enrollment target is 213 participants. The study started on 2025-08-18. Estimated completion is 2027-03-01.
What conditions does trial NCT07186816 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT07186816?
The interventions under investigation include: Behavioral: Supported dCBT (DEVICE), Behavioral: Unsupported dCBT (DEVICE).
Who is sponsoring clinical trial NCT07186816?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07186816 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07186816's enrollment target sits among peer trials
213 15th of 40 higher than 26 of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
-
Training in Evidence-based Treatments in Psycho-Oncology
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI